NeoCirc-001A completed!
Monday, July 27, 2015
NeoCirc-001A has recruited the required number of babies needed to determine the half-life of dobutamine in the two sites that had opened, the Royal Brighton and Sussex Hospital in UK and the LaPaz Hospital in Madrid, Spain. INSERM’s lab will soon analyse the blood samples from Madrid and Brighton and provide results. The trial report is being prepared by the trial sponsor SERMAS.